Retisert Bausch & Lomb - Treatment for Chronic Non-Infectious Uveitis

Retisert is an intravitreal implant containing a tiny reservoir of the anti-inflammatory corticosteroid fluocinolone acetonide, which is delivered for approximately two-and-a-half years directly to the back of the eye. Retisert is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Latest FDA Drug Approvals...

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals